Pancreatic Cancer Research

ResearcherResearch Institute for Gastroenterology and Liver DiseasesActive in the last 2 years

Hamid Asadzadeh Aghdaei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5589-8856; OpenAlex author ID A5072254700. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 9

  1. Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review. Co-author DOI 10.1002/hsr2.70412↗
  2. Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts. Co-author DOI 10.1186/s13099-025-00698-0↗
  3. Correction: Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts. Co-author DOI 10.1186/s13099-025-00710-7↗
  4. Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease stud… Co-author DOI 10.1371/journal.pone.0288755↗
  5. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Co-author DOI 10.3390/biom12050652↗
  6. Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients. Co-author DOI 10.3390/ijms222312978↗
  7. Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods. Last author DOI 10.1038/s41598-020-64569-1↗
  8. MicroRNAs Targeting MYC Expression: Trace of Hope for Pancreatic Cancer Therapy. A Systematic Review. First author DOI 10.2147/cmar.s245872↗
  9. TGF-β1 polymorphisms -509 C>T and +915 G>C and risk of pancreatic cancer. Last author PMID 28496942↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heidelinde Sammallahti · 4 shared papers, 2021–2025 · strength 0.76
  2. Pauli Antero Puolakkainen · 4 shared papers, 2021–2025 · strength 0.76
  3. Virinder Kaur Sarhadi · 4 shared papers, 2021–2025 · strength 0.76
  4. Sakari Knuutila · 4 shared papers, 2021–2025 · strength 0.76
  5. Amir Sadeghi · 4 shared papers, 2020–2025 · strength 0.72
  6. Mehdi Azizmohammad Looha · 3 shared papers, 2023–2025 · strength 0.70
  7. Mohamad Amin Pourhoseingholi · 1 shared paper, 2023 · strength 0.24
  8. Maedeh Amini · 1 shared paper, 2023 · strength 0.24
  9. Seyed Amir Ahmad Safavi‐Naini · 1 shared paper, 2025 · strength 0.23
  10. Aryan Salahi‐Niri · 1 shared paper, 2025 · strength 0.23
  11. Soudeh Ghafouri‐Fard · 1 shared paper, 2020 · strength 0.13
  12. Roshanak Shams · 1 shared paper, 2020 · strength 0.13
  13. Mohammad Reza Zali · 1 shared paper, 2020 · strength 0.13
  14. Roshanak Shams · 1 shared paper, 2020 · strength 0.13
  15. Ali Behmanesh · 1 shared paper, 2020 · strength 0.13
  16. José M Padrón · 1 shared paper, 2020 · strength 0.13
  17. Faegheh Behboudi Farahbakhsh · 1 shared paper, 2017 · strength 0.07
  18. Amir Houshang Mohammad Alizadeh · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.